Login

Journal Front Page

News & Events

  • April 2024 Issue delayed
  • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, Volume 13, Issue 2 (April 2024) Issue) schedule published on 15 April 2024 is delay due to some technical problem. It will published on 22 April 2024. Sorry for inconvenience. For other details You can vist the website http://www.ajper.com
  • Call for article for April 2024 issue
  • Submissions of Review, Research Article, Short Communication and Case study are being accepted for the current and future issues before 15 March, 2024 of this journal by online process or editor@ajper.com, or ajper.editor@gmail.com. Further information can be found at www.ajper.com.
  • January 2024 Issue published
  • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, has successfully launch Volume 13, Issue 1 (January 2024) Issue). You can find the article on http://ajper.com/current_issue.php Article also invited for the Next coming Issue from your side. For More details Visit: www.ajper.com
  • Application For Reviewer
  • We are now going to reconstitute our editorial board members of Reviewer. Please send your resume at ajper.editor@gmail.com and be a part of the editorial board member as Reviewer.
  • AJPER Impact facor
  • It is to pleasure that Ajper SJIF imact facor has increse from 5.019 to 7.014. Also global impact factor incresed from 0.654 to 0.765.
  • ICV
  • AJPER Rank with Index Copernicus Value 61.10 due to high reputation at International Level

Abstract

FAST DISSOLVING ORAL FILM: A BOON FOR PATIENTS SUFFERING WITH NAUSEA AND VOMITING

Sakshi Chandrakant Wankhede*, Pankaj M. Pimpalshende, Satish B. Kosalge

Hi-Tech college of Pharmacy, Padoli, Chandrapur (M.H)

ABSTRACT

For patients receiving chemotherapy and radiation therapy, nausea and vomiting are serious issues. Moreover, post-operative nausea and vomiting are common side effects. Postoperative nausea and vomiting (PONV) is thought to occur in 25–30% of cases. Furthermore, oral thin films provide accurate and adaptable dosing. Oral films are made easier and more convenient by these qualities, which also have positive medicinal effects. Drugs are rapidly absorbed in the mouth when administered via buccal or sublingual film delivery. This reduces exposure to the gastrointestinal system and addresses issues that are frequently related to tablets and capsules, including first-pass metabolism, gastrointestinal adverse effects, and sluggish or restricted absorption in the GI tract. Consequently, buccal or sublingual films might provide increased patient compliance, decreased adverse effects, and higher absorption. This article provides a thorough understanding of emesis, including its causes, treatments for emesis, innovative oral thin-film drug delivery, its properties, methods for fabrication and assessment, and, finally, previously published research on antiemetic oral thin-film.

Keywords: vomiting, emesis, oral thin film, the degree of bioavailability innovative method of medication administration.


[Full Text Article]